NCT07407725Recruiting
Clinical Outcome Assessment for AT & BCI
Development of a Clinical Outcome Assessment for Assistive Technologies and Brain-Computer-Interfaces
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
Many individuals with severe motor impairments rely on Assistive Technologies (ATs) or Brain-Computer Interfaces (BCIs) to interact with digital devices such as their computers. Clinicians and researchers currently lack a common framework to objectively quantify how much a given AT or BCI improves real-world function or to compare across tools. This project seeks to address this gap by developing a standardized method to objectively assess or compare the functional benefit of these tools on digital independence, i.e., the ability to independently operate computers, phones, and other digital systems, by creating a unique Digital Assessment Interface (DAI). This assessment will be a simulation of online and digital activities that prior work has determined is important to functional daily living in the digital domain. Participants will complete this assessment with various ATs and BCIs, and these scores will be used to create an index, which will be comprised of performance outcomes, clinician-reported outcomes, and patient-reported outcomes. The tool aims to quantify and compare digital task performance across devices and user populations. The primary objective of this study is to develop an index. The index will quantify functional performance of individuals using various ATs and BCIs. The secondary objectives are to extensively evaluate the psychometric properties of the index, such as the validity, responsiveness, reliability, and floor/ceiling effects both globally and across different devices and impairment levels, ensuring that it can reliably measure the impact of an AT or BCI on a user's ability to independently operate digital systems; and to characterize the familiarization and use of specific BCI and AT systems with reference to a normative healthy control population.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 22 Jan 2026
- Start date
- 8 Jan 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- Shirley Ryan AbilityLab
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT07407725
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 8 Jan 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior diagnosis or condition that could confound study assessments.
Other
- Participation in another trial that would conflict with the current study or clinical endpoint interference may occur.
- Amyotrophic Lateral Sclerosis (ALS):
- ● Participation in another trial that would conflict with the current study or clinical endpoint interference may occur.
- Healthy Controls:
- Participation in another trial that would conflict with the current study or clinical endpoint interference may occur;
- Cognitive, visual, or auditory deficits that would interfere with study participation;
Who the study is looking for
- Age at or above 18 years old;
- Diagnosis of spinal cord injury, at the level of T1 or above levels (between C1 and T1);
- Ability to communicate independently or with a support device, or with a legal representative;
- Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed.
- Age at or above 18 years old;
- Diagnosis of amyotrophic lateral sclerosis;
- Ability to communicate independently, with a support device, or with a legal representative;
- Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed.
- Age at or above 18 years old;
- No history of neurological or psychiatric disorders;
- Ability to provide written informed consent;
- Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed.
Criteria the registry did not label
- Enrollment will involve three different cohorts, namely a cohort of healthy participant, a cohort of ALS/SCI participant who underwent the implant of an invasive BCI device, and a cohort of ALS/SCI participants without any implanted BCI device.
- Below are listed the inclusion and exclusion criteria for each diagnostic group.
- Spinal Cord Injury (SCI):
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shirley Ryan AbilityLab Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.